Form D · Other Technology

BAR HARBOR BIOTECHNOLOGY INC

Trenton, ME · CIK 0001376286

Offering snapshot reported Mar 20, 2015 · SEC filing

Reported sold
$180K
Offering amount: $300K
Investors reported
3
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Mar 19, 2015
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 20, 2015Initial$180,000No comparison3SEC filing
May 20, 2011Initial$280,000No comparison2SEC filing
Jun 1, 2010Initial$25,000No comparison1SEC filing
Sep 19, 2006PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-236379
Equity: Series A Convertible Participating Preferred Stock

Source: Form D, filed Mar 20, 2015. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Dan Corey Director
Philip J. Ferneau Director
Phillip J. Ferneau Director
Jason W. Ingle Director
Robert Phelps Director, Executive
Mary Riley Director
Ed Robinson Director
Derry C. Roopenian Director, Executive
Daniel Schaffer Executive
Janet Yancey Wrona Executive

Issuer details

Industry: Other Technology (See others in industry)

Address:
18 Riverfield Rd
Trenton, ME, 04605